Add to Favorites Newsroom RSS Share
New York, NY USA

Our News on Newswise

Study Finds Rate of Mastectomies Decreases with Adoption of Breast Tumor Margin Guidelines: What This Means in the Overtreatment Debate for Breast Cancer

In a dramatic shift since the publication of margin guidelines for breast cancer surgery, lumpectomy rates have substantially increased and more-aggressive surgical options have been used less often, according to research findings from a new study...
1-Jun-2017 5:45 PM EDT Add to Favorites

Real-Time, Patient-Reported Symptom Monitoring Demonstrates an Overall Survival Benefit

Updated results of a clinical trial that launched in 2007 were presented today by Ethan Basch, MD, of Memorial Sloan Kettering Cancer Center (MSK) and UNC Lineberger Comprehensive Cancer Center, at the annual meeting of the American Society of...
2-Jun-2017 7:30 AM EDT Add to Favorites

Phase III Trial of PARP Inhibitor Shows First Evidence of Improved Outcomes in Breast Cancer

The first phase III trial of a PARP inhibitor used to treat breast cancer reported promising data at the annual meeting of the American Society of Clinical Oncology (ASCO). Mark Robson, MD, Clinic Director of the Clinical Genetics Service and...
1-Jun-2017 5:30 PM EDT Add to Favorites

Results Indicate That Larotrectinib Is Effective as the First Novel Targeted Therapy to Show a Consistent Response across Multiple Tumor Types in Adult and Pediatric Patients

Larotrectinib (LOXO-101) has demonstrated consistent and durable antitumor activity in tropomyosin receptor kinase (TRK) fusion cancers across a wide range of patient ages and tumor types and was well tolerated by patients, according to results from...
1-Jun-2017 5:35 PM EDT Add to Favorites

Novel Sequencing Approach Seeks to Detect Cancer’s Genomic Alterations

Findings from an early study evaluating a sophisticated new genomic-sequencing approach that analyzes cell-free DNA (cfDNA) in the blood of people with advanced cancer will help inform development of a future assay that could potentially detect...
1-Jun-2017 5:30 PM EDT Add to Favorites

Landmark Analysis From Memorial Sloan Kettering Reveals Genomic Tumor Sequence of More Than 10,000 Cancer Patients Using MSK-IMPACT™

Memorial Sloan Kettering (MSK) has reached a major milestone in bringing personalized treatments to more cancer patients. Michael Berger, PhD, Ahmet Zehir, PhD, and colleagues have reported an in-depth analysis of the first 10,336 patients whose...
8-May-2017 11:05 AM EDT Add to Favorites

World-Renowned Medical Oncologist Luis Diaz, MD, Named Head of the Division of Solid Tumor Oncology at Memorial Sloan Kettering Cancer Center

Luis A. Diaz, MD, has been named the Head of the Division of Solid Tumor Oncology in the Department of Medicine at Memorial Sloan Kettering (MSK). An accomplished physician, pioneering researcher, and leader in the field of clinical oncology, Dr....
17-Apr-2017 3:00 PM EDT Add to Favorites

Memorial Sloan Kettering Expertise on Precision Medicine Highlighted in American Association for Cancer Research Annual Meeting Press Program

Research findings from Memorial Sloan Kettering Cancer Center (MSK) will be featured in this year’s American Association for Cancer Research (AACR) Annual Meeting press program. The AACR is the oldest and largest professional organization...
31-Mar-2017 3:00 PM EDT Add to Favorites

Our YouTube Videos





Chat now!